Page 57 - product-manual

TM/MC TM/MC
REFERENCES

AgriLIFE Extension, Texas A&M System. Toxic Plants of Texas. Silktree, Mimosa (Albizia julibrissin). Deparment of Ecosystem Science & Management. Accessed: November
29, 2011. Available at: http://essmextension.tamu.edu/plants/toxics/default.aspx

Ang-Lee MK, Moss J, Yuan CS. (2001). Herbal medicines and perioperative care. JAMA. 286: 208-16.

Benke D, Barberis A, Kopp S, et al. (2009). GABA A receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts.
Neuropharmacology. 56:174-81.

Blumenthal M, Goldberg A, Brinckmann J. (2000). Herbal Medicine: Expanded Commission E Monographs. American Botanical Council. Boston (MA): Integrative Medicine
Communications.

Bone K. (2001). Clinical Applications of Ayurvedic and Chinese Herbs. Queensland (Australia): Phytotherapy Press.

Brinker F. (1998). Herb Contraindications and Drug Interactions. 2nd ed. Sandy, OR: Eclectic Medical Publications.

Carrasco MC, Vallejo JR, Pardo-de-Santayana M, et al. (2009). Interactions of Valeriana officinalis L. and Passiflora incarnata L. in a patient treated with lorazepam
Phytotherapy Research. 23:1795-6.

Chang HM & But PP. (1987). Pharmacology and Applications of Chinese Materia Medica Volume 2. World Scientific, Singapore.

Chen FP, Jong MS, Chen YC, et al. (2009). Prescriptions of Chinese Herbal Medicines for Insomnia in Taiwan during 2002. Evidence Based Complementary and Alternative
Medicine.

Chen JK, Chen TT. (2004). Chinese Medical Herbology and Pharmacology. California (USA). Art of Medicine Press.

Chizzola R, Hochsteiner W, Hajek S. (2004). GC analysis of essential oils in the rumen fluid after incubation of Thuja orientalis twigs in the Rusitec system. Research in
Veterinary Science. 76:77-82.

Dalla Corte CL, Fachinetto R, Colle D, et al. (2008). Potentially adverse interactions between haloperidol and valerian. Food and Chemical Toxicology. 46:2369-75.

Dharmananda S. (2001). ‘Zizyphus’. Institute for Traditional Medicine, Portland, Oregon, USA. Accessed: November 29, 2011. Available at: itmonline.org.

European Medicines Agency (EMEA). (2008). Evaluation of Medicines for Human Use. Assessment Report on Passiflora incarnate L., Herba. London. EMEA
HMPC/230961/2006.

European Medicines Agency (EMEA). (2007). Evaluation of Medicines for Human Use. Assessment Report on Valeriana officinalis L., Radix. London. EMEA/
HMPC/167391/2006.

Holzl J, Godau P. (1989). Receptor binding studies with Valeriana officinalis on the benzodiazepine receptor. Planta Medica, 155:642.

Houghton PJ. (1999). The scientific basis for the reputed activity of Valerian. The Journal of Pharmacy and Pharmacology. 51:505-12.

Kim JH, Kim SY, Lee SY, Jang CG. (2007). Antidepressant-like effects of Albizzia julibrissin in mice: involvement of the 5-HT1A receptor system. Pharmacology, Biochemistry
and Behavior. 87:41-7.

Kim WK, Jung JW, Ahn NY, et al. (2004). Anxiolytic-like effects of extracts from Albizzia julibrissin bark in the elevated plus-maze in rats.
Life Sciences. 75:2787-95.

Krenn L. (2002). Passion Flower (Passiflora incarnata L.) – A reliable herbal sedative (in German). Wiener Medizinische Wochenschrift. 152:404-6.

8 | Anzio-VM TM